CCP Antibody Test

What is a CCP antibody test?

A CCP antibody test detects anti-cyclic citrullinated peptide (anti-CCP) antibodies in the blood. These antibodies are autoantibodies, meaning they are produced by the immune system but mistakenly target the body’s own healthy tissues.

Anti-CCP antibodies primarily target tissues in the joints. Their presence in the blood may indicate rheumatoid arthritis (RA), an autoimmune disease that causes joint pain, swelling, stiffness, and progressive loss of joint function.

Anti-CCP antibodies are present in most people with rheumatoid arthritis and are rarely detected in people without the disease.

Other names: cyclic citrullinated peptide antibody, anticitrullinated peptide antibody, citrulline antibody, anti-cyclic citrullinated peptide, anti-CCP antibody, and ACPA.

What is the test used for?

The CCP antibody test is used to help diagnose or rule out rheumatoid arthritis.

It is commonly performed along with, or after, a rheumatoid factor (RF) test. RF can occur in other autoimmune diseases and may also be present in some healthy individuals. Conversely, some patients with rheumatoid arthritis have little or no RF. Therefore, using both anti-CCP and RF results can provide greater diagnostic accuracy than RF testing alone.

Why might a CCP antibody test be needed?

The test may be considered in patients with symptoms suggestive of rheumatoid arthritis, including:

  • Joint pain
  • Joint stiffness, particularly in the morning
  • Joint swelling
  • Fatigue
  • Low-grade fever

It may also be performed when other investigations have not confirmed or excluded rheumatoid arthritis.

How is the test performed?

A healthcare professional collects a blood sample from a vein in the arm using a small needle. A small amount of blood is placed into a test tube or vial.

The procedure usually takes less than five minutes. There may be a brief stinging sensation when the needle is inserted or removed.

Is any preparation required?

Inform your healthcare provider about all medicines, vitamins, and dietary supplements you are taking. Depending on the test and laboratory instructions, you may be asked to stop certain substances for approximately 8 hours before testing.

Are there any risks?

There is very little risk associated with a blood test. Mild pain or bruising may occur at the needle-insertion site, but these effects generally resolve quickly.

What do the results mean?

A positive result indicates that anti-CCP antibodies were detected in the blood, whereas a negative result means that they were not detected.

The significance of the result should be interpreted together with the patient’s symptoms, physical examination, RF results, and other investigations.

In a patient with symptoms suggestive of rheumatoid arthritis:

  • Anti-CCP positive + RF positive: rheumatoid arthritis is likely.
  • Anti-CCP positive + RF negative: may indicate early rheumatoid arthritis or an increased likelihood of developing rheumatoid arthritis in the future.
  • Anti-CCP negative + RF negative: rheumatoid arthritis is less likely, although additional evaluation may be required to determine the cause of symptoms.

Anti-CCP antibodies may occasionally be detected in other conditions, including:

  • Other autoimmune diseases, such as Sjögren syndrome or systemic lupus erythematosus
  • Active tuberculosis
  • Chronic lung disease

Therefore, CCP antibody results should always be interpreted in the context of the patient’s clinical history, examination findings, and other investigations.

Other investigations in suspected rheumatoid arthritis

Because rheumatoid arthritis can be difficult to diagnose, particularly during its early stages, additional investigations may be required. These can include:

  • Rheumatoid factor (RF)
  • Erythrocyte sedimentation rate (ESR)
  • C-reactive protein (CRP)
  • Antinuclear antibody (ANA)
  • Synovial fluid analysis
  • Joint X-rays

ESR and CRP may demonstrate evidence of systemic inflammation, which can support the clinical assessment but are not specific for rheumatoid arthritis.

Key point: Anti-CCP testing is an important laboratory tool in the evaluation of suspected rheumatoid arthritis, but the result should not be interpreted in isolation.

Bacterial meningitis in older children: Antibiotic choice and duration

Pediatric infectious diseases • High-yield clinical notes

Bacterial Meningitis in Older Children

Antibiotic choice, pediatric doses, organism-specific duration, and practical management points based on the Nelson approach.

Nelson-based • School-aged children & adolescents

01. Initial approach

In an older child with suspected acute bacterial meningitis, treatment must begin urgently after blood cultures and lumbar puncture, if these can be obtained without delaying antibiotics.

Initial empirical treatment should cover the most likely pathogens, particularly Streptococcus pneumoniae and Neisseria meningitidis.

Clinical priority Do not delay antibiotics for CT or lumbar puncture when LP is unsafe or would substantially delay treatment. Obtain blood cultures if feasible, but start antibiotics promptly.

Regimen selection depends on age, immunization status, local antimicrobial resistance, allergy history, and whether the infection is community-acquired or healthcare-associated.

02. Empirical antibiotic therapy

For children older than 3 months, including school-aged children and adolescents, the classic empiric regimen is:

First-line empiric treatment
Ceftriaxone + Vancomycin
OR
Cefotaxime + Vancomycin

Administer intravenously at meningitis doses while awaiting CSF Gram stain, culture, and susceptibility results.

Why add vancomycin? The third-generation cephalosporin covers common bacterial meningitis pathogens. Vancomycin adds coverage against potentially cephalosporin-resistant pneumococci.

Pediatric meningitis doses

Ceftriaxone

100 mg/kg/day IV

Usually once daily, or 50 mg/kg/dose every 12 hours.

Cefotaxime

200 mg/kg/day IV

Divide into doses every 6 hours in the cited Nelson regimen.

Vancomycin

60 mg/kg/day IV

Divide into doses every 6 hours in the cited Nelson regimen. Monitor according to institutional protocol.

Dose and safety note Confirm the current maximum dose, renal adjustment, infusion details, and vancomycin therapeutic drug monitoring requirements using your local pediatric antimicrobial protocol.

03. Antibiotic duration by organism

The following durations represent classic durations for uncomplicated bacterial meningitis. Modify treatment according to culture, susceptibility, clinical response, CSF sterilization, and complications.

Organism Preferred treatment and total duration
Streptococcus pneumoniae Ceftriaxone or cefotaxime if susceptible. 10–14 days.
If resistant to penicillin and third-generation cephalosporins, continue an active regimen guided by susceptibility, including vancomycin when indicated.
Neisseria meningitidis Penicillin G if susceptible, or ceftriaxone/cefotaxime. 5–7 days.
Haemophilus influenzae Ceftriaxone or cefotaxime, particularly for beta-lactamase-producing strains. 7–10 days.
Unknown bacterial pathogen Ceftriaxone or cefotaxime. 7–10 days may be appropriate in an uncomplicated, clinically improving child when the CSF profile supports bacterial meningitis but no organism is identified.
Gram-negative bacilli Use an active agent such as cefotaxime, ceftazidime, or another susceptibility-directed antibiotic. Treatment is generally prolonged, often at least 3 weeks in the classic regimen.

Other clinically important pathogens

Pathogen Treatment and duration
Listeria monocytogenes Ampicillin; usually at least 21 days in high-risk patients.
Group B Streptococcus Usually 14–21 days.
Pseudomonas aeruginosa An active antipseudomonal agent, such as ceftazidime or cefepime, selected according to susceptibility. Prolonged treatment is often required.
Remember Listeria and group B streptococcal meningitis are especially relevant in neonates and selected immunocompromised patients. Gram-negative and complicated infections require individualized treatment.

04. Culture-directed treatment

Once the CSF Gram stain, culture, PCR, and susceptibility results become available, narrow therapy to the most appropriate active antibiotic.

1

Suspected bacterial meningitis

Start ceftriaxone or cefotaxime plus vancomycin IV.
2

Identify the pathogen

Review CSF Gram stain, culture, PCR, and antimicrobial susceptibility results.
3

Narrow the antibiotic regimen

Stop vancomycin when it is no longer needed and the identified organism is adequately covered by the selected beta-lactam, provided susceptibility and clinical circumstances support de-escalation.
4

Complete the appropriate course

Continue organism-specific treatment, accounting for effective therapy, prior antibiotics, clinical response, complications, and CSF sterilization.

When should vancomycin be continued?

Continue vancomycin when there is a meaningful possibility of cephalosporin-resistant pneumococcal meningitis, until susceptibility results permit narrowing.

If the pneumococcus is susceptible to ceftriaxone or cefotaxime, a third-generation cephalosporin can generally be used alone.

Severe immediate beta-lactam allergy Alternative therapy requires specialist guidance. Chloramphenicol is discussed as an alternative in some Nelson regimens for children older than 1 month, but local resistance, availability, toxicity, and susceptibility must be considered.

05. Practical bedside points

Urgency
Do not delay antibiotics for CT or an unsafe or substantially delayed lumbar puncture.
CSF sterilization
With appropriate therapy, CSF generally becomes sterile within 24–48 hours in susceptible bacterial meningitis.
Repeat LP
Not routine in an uncomplicated, clinically improving case. Consider it for resistant pneumococcal disease, gram-negative meningitis, poor response, or suspected failure of sterilization.
Dexamethasone
Consider the first dose immediately before or concurrently with the first antibiotic dose when indicated, particularly when pneumococcal or Hib meningitis is suspected.
Warning: suspected meningitis This is a medical emergency. Stabilize airway, breathing, and circulation, manage seizures and shock, and administer empiric antibiotics promptly. Adapt management to the child’s clinical condition and local protocol.

06. Exam-oriented recall

A 9-year-old child presents with acute bacterial meningitis. Before culture results are available, what is the most appropriate empiric regimen?

Correct answer: B — Ceftriaxone + vancomycin.
This combination provides empiric coverage of common bacterial meningitis pathogens, including potentially resistant Streptococcus pneumoniae. Once culture and susceptibility results are available, therapy should be narrowed appropriately.

07. Rapid revision

Question High-yield answer
Empiric therapy in older children? Ceftriaxone or cefotaxime + vancomycin.
Typical pneumococcal duration? 10–14 days.
Typical meningococcal duration? 5–7 days.
Typical Hib duration? 7–10 days.
When can vancomycin be stopped? When susceptibility and clinical circumstances support narrowing.
Should LP delay antibiotics? No.

08. References and clinical note

Primary reference: Nelson Textbook of Pediatrics — bacterial meningitis: initial antibiotic therapy and duration of treatment.

Additional clinical guidance: Canadian Paediatric Society — Management of bacterial meningitis

Important: Confirm the current edition-specific Nelson recommendations, maximum doses, local antimicrobial resistance patterns, and institutional pediatric antimicrobial protocol before applying treatment to a patient.

Exit mobile version